Justine Y. Bruce
Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Justine Y. Bruce

Oncology | Palliative Medicine | Hematology
UW Health
University Of Wisconsin Medical Foundation Inc
600 Highland Ave, 
Madison, WI 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
UW Health
University Of Wisconsin Medical Foundation Inc
600 Highland Ave, 
Madison, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Justine Bruce is an Oncologist and a Palliative Medicine provider in Madison, Wisconsin. Dr. Bruce is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Laryngeal Cancer, and Medullary Thyroid Carcinoma. Dr. Bruce is currently accepting new patients.

Her clinical research consists of co-authoring 46 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Palliative Medicine
Hematology
Licenses
Hospice and Palliative Medicine in WI
Hospital Affiliations
University Of Wi Hospitals & Clinics Authority
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
600 Highland Ave, Madison, WI 53792
Call: 608-263-6400
Other Locations
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
4131 Meridian Dr, Windsor, WI 53598
Call: 608-846-3741

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Enrollment Status: Terminated
Publish Date: October 09, 2025
Intervention Type: Drug
Study Phase: Phase 1
Therapeutic Combination of CLR 131 With External Beam Radiation in Head and Neck Cancer
Therapeutic Combination of CLR 131 With External Beam Radiation in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: September 02, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Pilot Study of Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
A Pilot Study of Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Terminated
Publish Date: March 10, 2025
Intervention Type: Drug
Study Drug: Ladiratuzumab Vedotin
Study Phase: Phase 2
A Window of Opportunity Trial of Cetuximab in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
A Window of Opportunity Trial of Cetuximab in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: Cetuximab
Study Phase: Phase 2
A Phase 1/2a Study to Evaluate the Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine in Adult Patients With Selected Solid Tumors
A Phase 1/2a Study to Evaluate the Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine in Adult Patients With Selected Solid Tumors
Enrollment Status: Completed
Publish Date: April 19, 2022
Intervention Type: Drug, Biological
Study Drugs: GEN-009 Adjuvant Vaccine, Nivolumab, Pembrolizumab
Study Phase: Phase 1/Phase 2
A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination With Ipilimumab in Patients With Melanoma, Non-Small Cell Lung Cancer, and Other Cancers
A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination With Ipilimumab in Patients With Melanoma, Non-Small Cell Lung Cancer, and Other Cancers
Enrollment Status: Completed
Publish Date: February 08, 2022
Intervention Type: Biological
Study Phase: Phase 1
View 7 Less Clinical Trials

46 Total Publications

Immunotherapy in Head and Neck Cancer.
Immunotherapy in Head and Neck Cancer.
Journal: Cancer treatment and research
Published: August 23, 2025
View All 46 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Shahid Shekhani
Oncology | Hematology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Shahid Shekhani
Oncology | Hematology

Mercy Health System Corporation

N2950 State Rd, Suite 67, 
Lake Geneva, WI 
 (56.0 miles away)
262-245-0535
Languages Spoken:
English, Hindi, Punjabi, Urdu
See accepted insurances
Offers Telehealth

Shahid Shekhani is an Oncologist and a Hematologist in Lake Geneva, Wisconsin. Dr. Shekhani is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lynch Syndrome, and Colorectal Cancer.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Douglas G. Mcneel
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Douglas G. Mcneel
Oncology

University Of Wisconsin Medical Foundation Inc

600 Highland Ave, 
Madison, WI 
 (0.1 miles away)
608-263-6400
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Douglas Mcneel is an Oncologist in Madison, Wisconsin. Dr. Mcneel is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Adult Soft Tissue Sarcoma, and Familial Prostate Cancer. Dr. Mcneel is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Christos E. Kyriakopoulos
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Christos E. Kyriakopoulos
Hematology Oncology | Hematology | Oncology

University Of Wisconsin Medical Foundation Inc

250 Doctors Ct, 
Johnson Creek, WI 
 (33.7 miles away)
920-699-3500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christos Kyriakopoulos is a Hematologist Oncology specialist and a Hematologist in Johnson Creek, Wisconsin. Dr. Kyriakopoulos is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Kyriakopoulos is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bruce's expertise for a condition
ConditionClose
    • Distinguished
    • Anaplastic Thyroid Cancer
      Dr. Bruce is
      Distinguished
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    • Laryngeal Cancer
      Dr. Bruce is
      Distinguished
      . Learn about Laryngeal Cancer.
      See more Laryngeal Cancer experts
    • Medullary Thyroid Carcinoma
      Dr. Bruce is
      Distinguished
      . Learn about Medullary Thyroid Carcinoma.
      See more Medullary Thyroid Carcinoma experts
    • Thyroid Cancer
      Dr. Bruce is
      Distinguished
      . Learn about Thyroid Cancer.
      See more Thyroid Cancer experts
    • Advanced
    • Adenoid Cystic Carcinoma
      Dr. Bruce is
      Advanced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Follicular Thyroid Cancer
      Dr. Bruce is
      Advanced
      . Learn about Follicular Thyroid Cancer.
      See more Follicular Thyroid Cancer experts
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      Dr. Bruce is
      Advanced
      . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
      See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
    • Papillary Thyroid Cancer
      Dr. Bruce is
      Advanced
      . Learn about Papillary Thyroid Cancer.
      See more Papillary Thyroid Cancer experts
    • Polymorphous Low Grade Adenocarcinoma
      Dr. Bruce is
      Advanced
      . Learn about Polymorphous Low Grade Adenocarcinoma.
      See more Polymorphous Low Grade Adenocarcinoma experts
    • Throat Cancer
      Dr. Bruce is
      Advanced
      . Learn about Throat Cancer.
      See more Throat Cancer experts
    View All 7 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Bruce is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Bruce is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Bone Tumor
      Dr. Bruce is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Cervical Cancer
      Dr. Bruce is
      Experienced
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Chromophobe Renal Cell Carcinoma
      Dr. Bruce is
      Experienced
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Clear Cell Sarcoma
      Dr. Bruce is
      Experienced
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved